Dr. Barry Dworkin

New medication for Hodgkin's patients who have failed to respond to all other treatments may soon be approved

Madely Health Headlines Commentary for July 15, 2011

Source:

FDA Panel Endorses Novel Drug for Lymphoma

 

Related posts:

  1. Breast cancer risk from hormone replacement needs perspective when compared to other contributing factors
  2. More information needed about woman's breast cancer before slamming Ontario Government for not covering breast-cancer drug
  3. New blood thinners add value to stroke prevention and quality of life
  4. Attacking B-cell lymphoma without chemotherapy using gold nanoparticle